Quarterly Reports and Pricing of Public Offering - Research Report on Zimmer, ResMed, ZIOPHARM, MSA, and Exelixis
Editor Note: For more information about this release, please scroll to bottom
NEW YORK, October 29, 2013 /PRNewswire/ --
Today, Analysts' Corner announced new research reports highlighting Zimmer Holdings, Inc. (NYSE: ZMH), ResMed Inc. (NYSE: RMD), ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP), Mine Safety Appliances Co. (NYSE: MSA), and Exelixis, Inc. (NASDAQ: EXEL). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Zimmer Holdings, Inc. Research Report
On October 24, 2013, Zimmer Holdings, Inc. (Zimmer) released its Q3 2013 results. Zimmer registered net sales of $1.1 billion, up 4.8% YoY in Q3 2013. The Company reported net earnings of $154.4 million in Q3 2013, compared to net income of $178.1 million in Q3 2012. Zimmer posted diluted EPS of $0.90 in Q3 2013, compared to diluted EPS of $1.02 in Q3 2012. Commenting on the results, David Dvorak, Zimmer President and CEO, said, "Zimmer achieved accelerated top-line growth in the third quarter, fueled by our innovative new product offerings and the focused execution of our global sales teams." Dvorak continued, "For the balance of 2013, we expect to continue building stockholder value through the ongoing execution of our growth, operational excellence and capital deployment strategies." The Full Research Report on Zimmer Holdings, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/9db9_ZMH]
--
ResMed Inc. Research Report
On October 24, 2013, ResMed Inc. (ResMed) released its Q3 2013 results. ResMed registered net revenue of $357.7 million, up 5.3% YoY in Q3 2013. The Company reported net income of $80.9 million, up 13.6% YoY in Q3 2013. ResMed posted diluted EPS of $0.56, compared to diluted EPS of $0.49 in Q3 2012. Mick Farrell, CEO of ResMed, commented, "The opportunities in sleep and respiratory care remain attractive; we continue to provide our customers with the right solutions to better manage their businesses while providing high quality products to improve compliance and patient care. We are focused on continuing to improve the quality of life for patients who suffer from sleep-disordered breathing and its related co-morbidities, such as cardiology and diabetes; respiratory disorders, including chronic obstructive pulmonary disease; preventing disease progression; and saving both in-patient and out-patient costs." The Full Research Report on ResMed Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/bd44_RMD]
--
ZIOPHARM Oncology, Inc. Research Report
On October 24, 2013, ZIOPHARM Oncology, Inc. (ZIOPHARM) announced the public offering price of $3.50 per share for its previously announced public offering of 14.3 million shares of common stock. According to the Company, all the shares being sold are made by ZIOPHARM, and it is expected to close on October 29, 2013, subject to customary closing conditions; the Company has granted the underwriters a 30-day option to purchase up to an additional approximately 2.1 million shares. ZIOPHARM reported that it intends to use the net proceeds from the public offering for the overall development of its drug candidates, including its synthetic biology candidates and small molecule candidates, and for general corporate and working capital purposes. The Full Research Report on ZIOPHARM Oncology, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/71ea_ZIOP]
--
Mine Safety Appliances Co. Research Report
On October 23, 2013, Mine Safety Appliances Co. (MSA) released its Q3 2013 results. MSA registered net sales of $278.2 million in Q3 2013, compared to net sales of $286.6 million in Q3 2012. Net income attributable to MSA was $19.5 million, up 1.4% YoY in Q3 2013. The Company reported diluted EPS of $0.52, compared to $0.51 in Q3 2012. William M. Lambert, MSA President and CEO, commented, "MSA's consolidated third quarter results reflect the combined impact of product certification delays resulting from the federal government's budget sequestration, a reduction in large order shipments and weaker than normal business conditions in mining markets around the world." The Full Research Report on Mine Safety Appliances Co. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/3b82_MSA]
--
Exelixis, Inc. Research Report
On October 15, 2013, Exelixis, Inc. (Exelixis) announced that it will release its Q3 2013 results after the market close on Wednesday, October 30, 2013. Exelixis reported that the release will be followed by the live webcast of its Q3 2013 conference call at 5:00 p.m. EDT/2:00 p.m. PDT. The Company stated that the webcast will be accessible through the Event Calendar page under Investors & Media section at its website. Exelixis noted that the replay will be available through the same website until 1:59 p.m. PST on November 30, 2013. The Full Research Report on Exelixis, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/73be_EXEL]
----
EDITOR NOTES:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
- For any urgent concerns or inquiries, please contact us at [email protected].
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts' Corner
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article